Evidence map›Paper›PMID 37072657›Full record

ArticleInternational journal of computer assisted radiology and surgery2023

Robotic versus freehand CT-guided radiofrequency ablation of pulmonary metastases: a comparative cohort study.

Edward W Johnston, Jodie Basso, Francisca Silva, Arafat Haris, Robin L Jones, Nasir Khan, Helen Lawrence, Jakob Mathiszig-Lee, James McCall, David C Cunningham and 1 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of computer assisted radiology and surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. [Expert Consensus on Precision Management of Pulmonary Nodules (2026 Version)].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Edward W JohnstonInterventional Radiology, Royal Marsden Hospital, 203 Fulham Road, London, SW36JJ, UK. Ed.Johnston@rmh.nhs.uk.ORCID http://orcid.org/0000-0002-8504-2968
Jodie BassoInterventional Radiology, Royal Marsden Hospital, 203 Fulham Road, London, SW36JJ, UK.
Francisca SilvaInterventional Radiology, Royal Marsden Hospital, 203 Fulham Road, London, SW36JJ, UK.
Arafat HarisInterventional Radiology, Royal Marsden Hospital, 203 Fulham Road, London, SW36JJ, UK.
Robin L JonesSarcoma Unit, Medical Oncology, Royal Marsden Hospital, 203 Fulham Road, London, SW36JJ, UK.
Nasir KhanInterventional Radiology, Royal Marsden Hospital, 203 Fulham Road, London, SW36JJ, UK.
Helen LawrenceDepartment of Anaesthesia and Perioperative Medicine, Royal Marsden Hospital, 203 Fulham Road, London, SW36JJ, UK.
Jakob Mathiszig-LeeDepartment of Anaesthesia and Perioperative Medicine, Royal Marsden Hospital, 203 Fulham Road, London, SW36JJ, UK.
James McCallInterventional Radiology, Royal Marsden Hospital, 203 Fulham Road, London, SW36JJ, UK.
David C CunninghamGastrointestinal Unit, Medical Oncology, Royal Marsden Hospital, 203 Fulham Road, London, SW36JJ, UK.
Nicos FotiadisInterventional Radiology, Royal Marsden Hospital, 203 Fulham Road, London, SW36JJ, UK. Nicos.Fotiadis@rmh.nhs.uk.
Royal Marsden NHS Foundation Trust · GB

Funding

Royal College of Radiologists Pump prime grant
6 · The paper itself

Abstract

purposeRadiofrequency ablation (RFA) is a curative treatment option for small lung metastases, which conventionally involves multiple freehand manipulations until the treating electrode is satisfactorily positioned. Stereotactic and robotic guidance has been gaining popularity for liver ablation, although has not been established in lung ablation. The purpose of this study is to determine the feasibility, safety, and accuracy of robotic RFA for pulmonary metastases, and compare procedures with a conventional freehand cohort.

methodsA single center study with prospective robotic cohort, and retrospective freehand cohort. RFA was performed under general anesthesia using high frequency jet ventilation and CT guidance. Main outcomes were (i) feasibility/technical success (ii) safety using Common Terminology Criteria for Adverse Events (iii) targeting accuracy (iv) number of needle manipulations for satisfactory ablation. Robotic and freehand cohorts were compared using Mann-Whitney U tests for continuous variables, and Fisher's exact for categorical variables.

resultsThirty-nine patients (mean age 65 ± 13 years, 20 men) underwent ablation of 44 pulmonary metastases at single specialist cancer center between July 2019 and August 2022. 20 consecutive participants underwent robotic ablation, and 20 consecutive patients underwent freehand ablation. All 20/20 (100%) robotic procedures were technically successful, and none were converted to freehand procedures. There were 6/20 (30%) adverse events in the robotic cohort, and 15/20 (75%) in the freehand cohort (P = 0.01). Robotic placement was highly accurate with 6 mm tip-to-target distance (range 0-14 mm) despite out-of-plane approaches, with fewer manipulations than freehand placement (median 0 vs. 4.5 manipulations, P < 0.001 and 7/22, 32% vs. 22/22, 100%, P < 0.001).

conclusionsRobotic radiofrequency ablation of pulmonary metastases with general anesthesia and high frequency jet ventilation is feasible and safe. Targeting accuracy is high, and fewer needle/electrode manipulations are required to achieve a satisfactory position for ablation than freehand placement, with early indications of reduced complications.

Indexed as

Catheter AblationLung NeoplasmsRadiofrequency AblationRobotic Surgical ProceduresAgedCohort StudiesHumansMaleMiddle AgedProspective StudiesRetrospective StudiesTomography, X-Ray ComputedTreatment OutcomeLung neoplasmsRadiofrequency ablationRoboticsTomographyX-ray computed

Identifiers

PMID37072657
PMCPMC10497639
OpenAlexW4366263867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.